Skip to main content
. 2019 Apr 5;32(4):321–329. doi: 10.20524/aog.2019.0375

Table 2.

Access to direct-acting antiviral agents (DAAs) in Greece according to fibrosis/cirrhosis status

graphic file with name AnnGastroenterol-32-321-g002.jpg